[Interstitial pulmonary disease in systemic scleroderma: treatment].
Hellmich
B
B
Medizinische Klinik und Poliklinik, AG Rheumatologie, Universitätsklinik Bergmannsheil, Ruhr-Universität Bochum, Germany. Bernhard.Hellmich@ruhr-uni-bochum.de
Schnabel
A
A
Bauer
T
T
Schatz
H
H
D001379:Azathioprine / Q000627:therapeutic use; D016207:Cytokines / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D017563:Lung Diseases, Interstitial / Q000209:etiology / Q000628:therapy*; D012595:Scleroderma, Systemic / Q000150:complications*
D016207:Cytokines; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D001379:Azathioprine